A purple and pink letter v on a white background.
August 27, 2019

How Pulse Duration Impacts Laser Hair Removal Treatments

Treatment technology has come a long way since the first laser hair removal device was approved by the U.S. Food and Drug Administration (FDA) in 1997. Over time, researchers have been able to develop safer treatment options that minimize the risk of post-inflammatory hyperpigmentation (PIH) for patients with darker skin tones and offer greater operator control with spot size selection, pulse duration modes, built-in cooling technology, and more.

Today, the top developments in laser hair removal technologies have reduced the post-treatment hair regrowth rate by up to 95%, with devices featuring diode laser technology that is safe for treating patients with darker skin tones and tanned skin. Delivering targeted heat through customized and controlled pulse rates and spot sizes to target hair follicles across a larger surface area, these developments in hair removal procedures reduce the risk of skin damage and improve treatment session times alongside patient comfort. Adjustable pulse width is a major factor in these developments.

How Pulse Duration Affects Patient Safety and Clinical Efficacy

One of four parameters that can improve the safety and effectiveness of laser hair removal treatments, pulse duration, which is also frequently called pulse width, refers to the time a device takes to deliver energy to a treatment area, or the time in which targeted tissue is exposed to laser energy. A key factor for determining optimal pulse duration for a particular treatment is thermal relaxation time (TRT).  

TRT refers to the more specific amount of time in which it takes targeted tissue to release more than 50% of the heat delivered with each energy pulse. Because laser energy transfers to thermal heat once it penetrates the epidermis, the temperature of targeted tissue rises with each pulse. As energy disperses at the end of the pulse duration, the targeted tissue cools but some heat is retained. For treatments to be effective, thermal energy needs to be retained in the targeted tissue, rather than allowing it to disperse into surrounding tissue. To achieve this effect, pulse duration must be faster than TRT. Generally speaking, for larger areas, longer pulse durations are required for adequate heating of the targeted tissue, while shorter pulse durations will deliver the same effect to smaller treatment areas.

Pulse duration is also a key measurement for providers treating patients with a wider range of skin tones. Supporting greater efficacy and safety for prospective patients with darker and tanned skin tones, a longer pulse duration decreases the risk of damaging surrounding epidermis, including post-inflammatory hyperpigmentation(darkening of the skin) and hypopigmentation (lightening of the skin). Faster, shorter pulses, on the other hand, offer a more effective treatment for those with lighter skin tones while minimizing potential discomfort during treatment.

Improving Patient Safety with Venus Velocity™’s PULSE and SLIDE Modes

What truly sets the Venus Velocity™ diode laser hair removal device apart is the versatility to not only choose among three changeable tips with varying spot sizes—large at 7 cm 2 , medium at 3.51 cm 2 , and small at 1.69 cm 2 —but to also choose between two different pulse duration modes of operation: SLIDE and PULSE.

Unlike similar diode laser systems on the market that only offer a fixed pulsed or slide mode, Venus Velocity™ allows the operator to choose between the two options to better customize treatments to individual patient needs:

  • PULSE Mode: Venus Velocity™’s PULSE mode delivers higher energy levels to targeted tissue at a lower repetition rate. When using PULSE mode, the applicator is placed on the skin, the trigger is pressed for one pulse, and is then immediately released before the applicator is moved to the next treatment spot where the process is repeated. This results in improved clinical efficacy, fewer treatment sessions, and improved patient comfort.

  • SLIDE Mode: Venus Velocity™’s SLIDE mode delivers a higher repetition rate of shorter energy pulses, achieving greater average power output while the operator glides the applicator over the treatment area. In SLIDE mode, the applicator is placed on the skin, the trigger is held down, and the tip remains in continuous contact with the skin as the applicator is smoothly and methodically moved along skin tissue. Smooth, continuous movement and contact ensures full treatment coverage with little to no discomfort for the patient, as well as decreased risk of discoloration or damage in those with darker skin tones.

Having the unique ability to use either mode of operation provides unparalleled versatility for hair removal treatments. The repetition rate can also be adjusted to provide a tailored solution for your patient’s preferred treatment technique and comfort level.

Interested in learning more about Venus Velocity™’s advanced features and diode laser treatment technology? Contact an expert today using the button below.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.